Back to News

2019 BFC Global Healthcare BD & Investment Conference


The St. Regis San Francisco – 125 3rd Street
San Francisco, CA

For the third year in a row, Cooley will sponsor the annual BFC Global Healthcare BD & Investment Conference.

The conference will feature key topics in the following areas:

  • Biotech capital market trends in both US and China
  • Licensing, the emerging trend among Chinese biotech companies
  • Key successful factors for Hong Kong and Nasdaq listing
  • Leading biotech company roadshows


Senior executives from more than 500 public & private healthcare companies across the biopharmaceuticals, IVD, medical device and healthcare services sectors attended this event in 2018. More than 300 PE and VC investors from over 100 firms also attended the 2018 conference.

The conference will provide an optimal environment for networking with senior executives of your potential partners. Company management teams and investors will also have the opportunity to participate in one-on-one and small group meetings through BFC Group.

Event details and registration

Featured agenda items

09:15 – 10:15 am: Cross-border Licensing Deal Trend – Perspectives From Leading Biopharma Players

Cooley partners Lila Hope and Christina Zhang will speak.

10:15 – 11:15 am: IPO Markets in US and Hong Kong – Getting the Best of Both Markets

Cooley partners Charlie Kim and Jonie Kondracki will speak.

Related Contacts
Christina Zhang Partner-in-Charge - Shanghai
Charlie Kim Partner, San Diego
Lila Hope Partner, Palo Alto
Jonie Kondracki Partner, San Francisco